Eighteen months on from the start of NHS England’s hepatitis C elimination deal, HCV Action’s annual ODN event, co-hosted with the British Viral Hepatitis Group, explored how the UK has progressed towards elimination. It particularly focused on overcoming the challenges posed by the significant disruption of Covid-19 on healthcare services. This year’s event was held as a half-day webinar due to coronavirus-related restrictions and welcomed 129 participants from almost all ODNs and partner services.
Resources
Medical professional
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Showing 81 to 90 of 418 resources
-
Summary report: National Hepatitis C ODN Stakeholder Event 2020
England 30 Oct 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF
-
Summary report: Mitigating the impact of COVID-19 on HCV testing
This is the written summary of a webinar held on 8th October on mitigating the impact of COVID-19 on HCV testing. The first part of the webinar consisted of three presentations: Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You; Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team; and Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow LiveUK, England 30 Oct 2020 Case study, Tools & Templates, Strategy & Planning PDF
-
Workshop webinar: Hepatitis C in the justice system - going beyond prisons
This is a recording of a webinar covering initiatives to test and treat people for hepatitis C in contact with the justice system in England, held on the 23rd October 2020. Previous events and initiatives in this area have aimed to support people in prisons. Whilst this is important and continues, this webinar focused on new initiatives for people in contact with other areas of the justice system, such as probation services. The webinar featured 3 talks:North East, UK 29 Oct 2020 Case study, Strategy & Planning Video
-
Webinar: Mitigating the impact of COVID-19 on hepatitis C testing
This is a recording of a webinar focusing on how services can mitigate the impact of COVID-19 on hepatitis C testing and find alternative ways to test people. The first part of the webinar consisted of three presentations: 1/ Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You 2/ Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team 3/ Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow LiveUK 22 Oct 2020 Case study, Tools & Templates, Strategy & Planning Video
-
Webinar: Under-served groups for hepatitis C testing and treatment
This webinar sought to look at how services can provide hepatitis C testing and treatment to people who have been traditionally under-served by health services. This workshop sought to discuss: - Sex workers - Gypsy, Roma and Traveller people - South Asian communities - Migrants For each of these groups, this video features a presentation exploring the general barriers to healthcare that they face and examples of projects which have improved access to healthcare for them along with a Q&A session at the end.UK 22 Oct 2020 Case study, Training, Strategy & Planning Video
-
Summary report: Hepatitis C case-finding in under-served groups - October 2020
This report summarises the October 2020 HCV Action webinar on hepatitis C case-finding in under-served groups, which formed part of a week-long series of webinars centred around the National Hepatitis C ODN Stakeholder Event. The webinar focused on four under-served groups in particular: Gypsy, Roma and Travellers; migrants; sex-workers, and the South Asian community. The webinar featured contributions from the following speakers: • Beth Davies – Head of Service and Development (Dorset), EDP Drug & Alcohol Services • Dr Inês Campos-Matos – Head of Migration Health, Public Health EnglandUK 22 Oct 2020 Reports & Research PDF
-
HCV Action ODN Stakeholder Event 2020: A national perspective on elimination
These are the opening talks from this year's ODN Stakeholder Event from Mark Gillyon-Powell, Head of Programme for HCV Elimination, NHS England and Prof Graham Foster, National Clinical Lead for ODNs, NHS England. The talks gives a national overview on hepatitis C elimination efforts in England and how COVID-19 has impacted these. Professor Guruprasad Aithal, President of the British Association for the Study of the Liver (BASL) chaired the event. We will be publishing a written summary of the other presentations from this event soon.England 07 Oct 2020 Other, Strategy & Planning Video
-
A glossary of contested terms in substance use
This is a glossary of terms used by people working in the drugs field, drawn up by the Scottish Drugs Forum. It covers some of the specialised and contentious language used in the field. We have included it in the resource library as it may be helpful to those who work in health services who are less familiar with some of the language and terms used by colleagues and partners in drug services.UK 07 Oct 2020 Training, Reports & Research PDF
-
Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2020 report
The 2020 edition of the Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID contains a number of relevant updates on hepatitis C among injecting drug users, including: • The proportion of UAM participants with antibodies to hepatitis C (HCV) (i.e. ever infected) who have markers of chronic infection (RNA) has decreased from 58% in 2011 when it was first measured to 42% in 2019; this corresponds with the timing of the scale-up of direct acting antiviral treatment against HCV among PWIDUK 06 Oct 2020 Reports & Research PDF
-
Understanding the Sexual Health and Blood Borne Virus Risk Behaviours of Defined 'at risk' Groups
This report outlines the findings of research with drug users and the staff that support them related to harms associated with chemsex, transactional sex; and the use of image and performance enhancing drugs (IPEDs). Twos aims of the report were to describe the risk-taking behaviours in relation to drug taking, sexual health and transmission of BBV (blood borne virus) of the three target groups and inform the development of a training programme for services providers on sexual health and blood borne viruses for the three defined groups.Scotland 07 Sep 2020 Reports & Research PDF